Developing methods

Developing precise, data-rich methods for early clinical drug research is one of the unique aspects of CHDR’s work. 2025 saw new developments in methods for neurology, immunology, infectious diseases, and more.

NeuroKit® ready for clinical studies in the USA

Utility function ranks opioids

In-depth insight into immunological challenge models allows for tailor-made approach

Virtual Reality as a tool to map the emotional side of pain

Ongoing innovations in recording electrical brain activity

Successful development of viral infection models

Oncology group builds on immunological challenge models

Valuable conclusions from existing EEG data

Laying the foundation for a new approach to metabolic studies

High-frequency stimulation: a novel model for chronic pain

‘Bringing one of the most informative CNS testing technologies to the USA’ - Dr William Martin, CEO Lotus Clinical Research

UVB pain model explored as a novel tool in immunology and oncology

First study in Twente focuses on measurements of excitability of the motor cortex

Candidate biomarkers for sustained DMT effects

Chikungunya model ready for testing vaccines and antivirals